Methods to Identify Genetic Markers That Interact with Multiple Environmental Exp
识别与多种环境实验相互作用的遗传标记的方法
基本信息
- 批准号:8431358
- 负责人:
- 金额:$ 15.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-02-17 至 2015-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressBreastCollaborationsComplexCoronary heart diseaseDataData SetDiseaseEnsureEnvironmentEnvironmental ExposureEnvironmental Risk FactorEpidemiologic StudiesGenesGeneticGenetic MarkersGenetic RiskHeart DiseasesHumanIndividualJointsLeadMalignant NeoplasmsMasksMeasuresMethodsModelingModificationMolecular EpidemiologyNon-Insulin-Dependent Diabetes MellitusOutcomePrevention programPublic Health SchoolsResearch PersonnelRiskRisk FactorsSeriesStagingStatistical MethodsStructureTestingVariantcancer typecase controlclinically relevantcohortdesigndisorder riskgene environment interactiongenetic epidemiologygenetic variantgenome wide association studyhuman diseaseimprovedinterestlead seriesperformance testsprogramssimulationsoftware developmentstatisticstooltraitvectorweb page
项目摘要
DESCRIPTION (provided by applicant): Common, complex diseases like cancer, heart disease and type 2 diabetes are multifactorial: risk for these diseases depends on multiple genetic and environmental factors. To date, however, epidemiological studies searching for genetic markers associated with disease risk have considered the effect of a single genetic factor, averaged over all other factors. If the effect of a genetic variant differs across strata defined by environmental exposures, then it is possible that the marginal approach will fail to detect the variant. In some situations, considering possible genetic effect modification by measured exposures can increase researchers' ability to detect genetic markers of disease. Most of the proposed methods for improving power to detect causal loci by considering gene-environment interaction focus on a single locus and a single environmental exposure. When more than one exposure might modify with a genetic effect, these methods force investigators either to guess a priori which exposure is the most likely modifier or to test individual exposures in series, leading to an increase in multiple testing penalty and a loss of power. We propose two analytic frameworks that flexibly model the interactions between a genetic marker and multiple measured exposures. We hypothesize that these approaches will be more powerful than tests that focus on a single exposure, or consider multiple exposures individually, in series. Successful completion of our aims will provide researchers with tools to improve their ability to identify genetic variants associated with complex human traits, which will in turn lead to a better understanding of the multifactorial mechanisms underlying human disease and potential improvements in risk prediction and prevention programs.
描述(由申请人提供):常见的,复杂的疾病,如癌症,心脏病和2型糖尿病是多因素的:这些疾病的风险取决于多种遗传和环境因素。然而,到目前为止,寻找与疾病风险相关的遗传标记的流行病学研究已经考虑了单个遗传因素的影响,平均超过所有其他因素。如果遗传变异的影响在由环境暴露定义的阶层中不同,那么边际方法可能无法检测到变异。在某些情况下,通过测量暴露量来考虑可能的遗传效应修改可以提高研究人员检测疾病遗传标记的能力。大多数通过考虑基因-环境相互作用来提高检测致病基因座的能力的方法都集中在单个基因座和单个环境暴露上。当一个以上的曝光可能会修改与遗传效应,这些方法迫使调查人员猜测先验的曝光是最有可能的修改器或测试个人曝光系列,导致多个测试惩罚的增加和权力的损失。我们提出了两个分析框架,灵活地模拟遗传标记和多个测量暴露之间的相互作用。我们假设,这些方法将比集中在一个单一的曝光,或考虑多个曝光单独,在一系列的测试更强大。我们的目标的成功完成将为研究人员提供工具,以提高他们识别与复杂人类特征相关的遗传变异的能力,这反过来又会导致更好地了解人类疾病的多因素机制,并潜在地改善风险预测和预防计划。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER KRAFT其他文献
PETER KRAFT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER KRAFT', 18)}}的其他基金
Prediagnostic exposures, germline genetics, and triple negative breast cancer mutational and immune profiles
诊断前暴露、种系遗传学以及三阴性乳腺癌突变和免疫特征
- 批准号:
10209573 - 财政年份:2021
- 资助金额:
$ 15.18万 - 项目类别:
Prediagnostic exposures, germline genetics, and triple negative breast cancer mutational and immune profiles
诊断前暴露、种系遗传学以及三阴性乳腺癌突变和免疫特征
- 批准号:
10396616 - 财政年份:2021
- 资助金额:
$ 15.18万 - 项目类别:
Leveraging cross-cancer shared heritability to better understand the genetic architecture of cancer
利用跨癌症共享遗传性更好地了解癌症的遗传结构
- 批准号:
10456715 - 财政年份:2015
- 资助金额:
$ 15.18万 - 项目类别:
Leveraging cross-cancer shared heritability to better understand the genetic architecture of cancer
利用跨癌症共享遗传性更好地了解癌症的遗传结构
- 批准号:
10665722 - 财政年份:2015
- 资助金额:
$ 15.18万 - 项目类别:
Leveraging cross-cancer shared heritability to better understand the genetic architecture of cancer
利用跨癌症共享遗传性更好地了解癌症的遗传结构
- 批准号:
9979308 - 财政年份:2015
- 资助金额:
$ 15.18万 - 项目类别:
Leveraging GxE interaction to understand pancreatic cancer and altered metabolism
利用 GxE 相互作用来了解胰腺癌和代谢改变
- 批准号:
8805140 - 财政年份:2015
- 资助金额:
$ 15.18万 - 项目类别:
Methods to Identify Genetic Markers That Interact with Multiple Environmental Exp
识别与多种环境实验相互作用的遗传标记的方法
- 批准号:
8218719 - 财政年份:2012
- 资助金额:
$ 15.18万 - 项目类别:
Sequencing regions assoc with breast cancer risk in European and African American
欧洲和非裔美国人中与乳腺癌风险相关的区域测序
- 批准号:
8005883 - 财政年份:2010
- 资助金额:
$ 15.18万 - 项目类别:
Evaluating the Clinical Validity of Novel Gene-Environment Risk Profiles
评估新基因环境风险概况的临床有效性
- 批准号:
7742455 - 财政年份:2009
- 资助金额:
$ 15.18万 - 项目类别:
相似海外基金
Intelligent Breast Cancer DiagnOsis and MonItoring Therapeutic Response Training Network (CanDoIt)
智能乳腺癌诊断和监测治疗反应训练网络(CanDoIt)
- 批准号:
EP/Y03693X/1 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
Research Grant
From single-cell transcriptomic to single-cell fluxomic: characterising metabolic dysregulations for breast cancer subtype classification
从单细胞转录组到单细胞通量组:表征乳腺癌亚型分类的代谢失调
- 批准号:
EP/Y001613/1 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
Research Grant
Preclinical validation of synthetic biomolecules to treat Breast Cancer from AI-enabled discovery of novel lncRNA therapeutic targets.
通过人工智能发现新型 lncRNA 治疗靶点,对合成生物分子治疗乳腺癌进行临床前验证。
- 批准号:
10110204 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
Launchpad
Quad negative breast cancerに対する新たなプレシジョン・メディシン治療戦略
四阴性乳腺癌精准医学治疗新策略
- 批准号:
24K11748 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ESR1 mutation profiling identifies potential drivers of metastatic breast cancer
ESR1 突变分析确定了转移性乳腺癌的潜在驱动因素
- 批准号:
MR/X018199/1 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
Research Grant
Spatial-BrTME: Multicellular spatial dynamics of immunotherapy response in breast cancer
Spatial-BrTME:乳腺癌免疫治疗反应的多细胞空间动力学
- 批准号:
EP/Y014995/1 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
Research Grant
Development of comprehensive PET imaging for precise diagnosis of breast cancer
开发用于乳腺癌精确诊断的综合PET成像
- 批准号:
23H02856 - 财政年份:2023
- 资助金额:
$ 15.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of internal radiation therapy agents for refractory breast cancer based on phase-shift using focused ultrasound
基于聚焦超声相移的难治性乳腺癌体内放射治疗剂的开发
- 批准号:
23H02866 - 财政年份:2023
- 资助金额:
$ 15.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The early detection of breast cancer using field cacerization.
使用现场癌症化早期检测乳腺癌。
- 批准号:
23K08094 - 财政年份:2023
- 资助金额:
$ 15.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role of CD44 bearing TJA-II binding glycans in therapy-resistant subset of triple negative breast cancer
携带 CD44 的 TJA-II 结合聚糖在三阴性乳腺癌耐药亚型中的作用
- 批准号:
23K06748 - 财政年份:2023
- 资助金额:
$ 15.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




